AUTL
Autolus Therapeutics
AUTL
AUTL
66 hedge funds and large institutions have $229M invested in Autolus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $272M → $229M (-$43.6M)
31% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 26
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
Holders
66
Holding in Top 10
1
Calls
$248K
Puts
$10K
Top Buyers
| 1 | +$7.57M | |
| 2 | +$2.08M | |
| 3 | +$2.07M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$1.59M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.12M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$7.9M | |
| 3 | -$1.3M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$720K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$712K |